PepGen Inc. (PEPG)
NASDAQ: PEPG · Real-Time Price · USD
3.080
+0.010 (0.33%)
Aug 28, 2026, 4:00 PM EDT - Market closed
PepGen Employees
PepGen had 57 employees as of June 30, 2026. The number of employees decreased by 5 or -8.06% compared to the same quarter last year.
Employees
57
Change
-5
Growth
-8.06%
Revenue / Employee
n/a
Profits / Employee
-$1,262,123
Market Cap
213.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 57 | -5 | -8.06% |
| Mar 31, 2026 | 59 | -20 | -25.32% |
| Dec 31, 2025 | 56 | -25 | -30.86% |
| Sep 30, 2025 | 57 | -19 | -25.00% |
| Jun 30, 2025 | 62 | -10 | -13.89% |
| Mar 31, 2025 | 79 | 14 | 21.54% |
| Dec 31, 2024 | 81 | 17 | 26.56% |
| Sep 30, 2024 | 76 | 13 | 20.63% |
| Jun 30, 2024 | 72 | 18 | 33.33% |
| Mar 31, 2024 | 65 | 16 | 32.65% |
| Dec 31, 2023 | 64 | 19 | 42.22% |
| Sep 30, 2023 | 63 | 23 | 57.50% |
| Jun 30, 2023 | 54 | 18 | 50.00% |
| Mar 31, 2023 | 49 | 18 | 58.06% |
| Dec 31, 2022 | 45 | 14 | 45.16% |
| Sep 30, 2022 | 40 | 17 | 73.91% |
| Jun 30, 2022 | 36 | 24 | 200.00% |
| Mar 31, 2022 | 31 | 19 | 158.33% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Coherus Oncology | 144 |
| Voyager Therapeutics | 141 |
| Immunic | 100 |
| Keros Therapeutics | 92 |
| Precision BioSciences | 67 |
| Acumen Pharmaceuticals | 61 |
| Corbus Pharmaceuticals Holdings | 36 |
PEPG News
- 24 days ago - PepGen reports Q2 EPS (26c), consensus (29c) - TheFly
- 24 days ago - PepGen to advance PGN-EDODM1 into highest dose cohort - TheFly
- 24 days ago - PepGen Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Business Wire
- 24 days ago - PepGen to Advance PGN-EDODM1 Into Highest Dose Cohort in Phase 2 FREEDOM2-DM1 Study Following DSMB Review - Business Wire
- 24 days ago - PepGen Quarterly report: Q2 2026 - Filings
- 24 days ago - PepGen Earnings release: Q2 2026 - Filings
- 24 days ago - PepGen Slides: Company presentation - Filings
- 2 months ago - Craig-Hallum bullish on PepGen, initiates with a Buy - TheFly